Pediatric Brain and Spinal Cord Tumors
Weill Cornell's Pediatric Brain Tumor Program is a multidisciplinary effort directed by highly trained clinicians with specific areas of expertise. From the moment of diagnosis, a program team – most often a neurologist, radiation therapist, neuroendocrinologist, and oncologist – join the neurosurgeon in developing a treatment plan. Together the team will select and manage the most effective combination of therapies for each patient. The team is committed to getting their young patients back to their normal childhoods – that means maximizing the impact of treatment while reducing potential risks so that the children can have an optimal prognosis for normal growth, sexual maturity, and cognitive performance.
At the Weill Cornell Pediatric Brain and Spine Center, advanced drug therapies are now being used in a study for children with malignancies of the central nervous system. In addition, studies are currently being conducted on novel approaches to treatment of pediatric tumors. Read more about an exciting new clinical trial that will test an innovative new treatment option for inoperable brain tumors in children, and find out how you can help.
Minimally Invasive Neurosurgery
Minimally invasive neurosurgery at Weill Cornell is an advanced program that was established more than a decade ago. Extensive experience in this technology has earned Weill Cornell national recognition as a center of excellence in minimally invasive surgery for the treatment of intraventricular brain tumors. An integral part of minimally invasive techniques is integrated stereotactic guidance, an advanced imaging system used during a surgical procedure to select the least invasive routes and minimize trauma to surrounding brain.
Pediatric Neuro-Oncology
Weill Cornell's pediatric neuro-oncology group is studying the hormonal and reproductive effects of brain tumors and their treatment. Additional studies are underway on the neuroendocrine aspects of pediatric brain tumors. In collaboration with New York University, studies are focusing on treatment outcomes in children with germ cell tumors. The studies are examining the effects of high-dose chemotherapy with bone marrow reconstitution for pediatric patients with recurrent germ cell tumors; and chemotherapy for patients with newly diagnosed germ cell tumors of the central nervous system. At Weill Cornell, radio-labeled monoclonal antibodies are being used in a study for children with disseminated malignancies of the central nervous system. In addition, studies are being conducted on local delivery systems to treat pediatric tumors.
Find out how you can help support our research, and help kids get back to being kids
Contact Us
For your convenience, we offer several options for scheduling an appointment.
Request an Appointment Online.
Phone
(866) 426-7787
(212) 746-4684
Office Hours
Monday - Friday, 9:00 AM to 5:00 PM
Emergency Department,
NewYork-Presbyterian/Weill Cornell
(212) 746-5026
